Jiksak Bioengineering

About:

Jiksak Bioengineering is a biotechnology research firm that develops, produces, and sells 3d cell tissue and cultural devices.

Website: https://www.jiksak.co.jp

Twitter/X: jiksakb

Top Investors: ANRI, Ohara Pharmaceutical, Essential Pharma, CEJ Capital, Media Future

Description:

Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).

Total Funding Amount:

170M JPY

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Kawasaki, Kanagawa, Japan

Founded Date:

2017-02-07

Contact Email:

jiro(AT)jiksak.co.jp

Founders:

Haruyoshi Kawada, Norihiro Yumoto

Number of Employees:

1-10

Last Funding Date:

2021-03-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai